rhapontigenin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 5320954 |
CHEMBL ID | 113029 |
CHEBI ID | 174376 |
SCHEMBL ID | 1486816 |
MeSH ID | M0393846 |
Synonym |
---|
AC-7022 |
5-[(e)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]benzene-1,3-diol |
CHEBI:174376 |
rhapontigenin |
500-65-2 |
CHEMBL113029 |
protigenin |
A827955 |
5-[2-(3-hydroxy-4-methoxy-phenyl)vinyl]benzene-1,3-diol |
3,3',5-trihydroxy-4'-methoxy-trans-stilbene |
trans-1-(3,5-dihydroxyphenyl)-2-(3-hydroxy-4-methoxyphenyl)ethylene |
R0089 |
S9163 |
AKOS015915122 |
(e)-5-(3-hydroxy-4-methoxystyryl)benzene-1,3-diol |
SCHEMBL1486816 |
5-[(1e)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]-1,3-benzenediol |
PHMHDRYYFAYWEG-NSCUHMNNSA-N |
HMS3648K18 |
5-[(1e)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]benzene-1,3-diol |
AS-68092 |
pontigenin |
HY-N2229 |
CS-0019552 |
mfcd00017718 |
rhapontin genin |
unii-22bg4nnh6w |
22bg4nnh6w , |
SR-01000946385-1 |
sr-01000946385 |
(e)-5-[2-(3-hydroxy-4-methoxyphenyl)ethenyl]-1,3-benzenediol |
BCP15039 |
Q7320232 |
AMY40675 |
CCG-267039 |
DTXSID501023634 |
?rhapontigenin |
5-((e)-2-(3-hydroxy-4-methoxyphenyl)ethenyl)benzene-1,3-diol |
5-((1e)-2-(3-hydroxy-4-methoxyphenyl)ethenyl)-1,3-benzenediol |
1,3-benzenediol, 5-((1e)-2-(3-hydroxy-4-methoxyphenyl)ethenyl)- |
3,3,5-stilbenetriol, 4-methoxy-, (e)- |
1,3-benzenediol, 5-(2-(3-hydroxy-4-methoxyphenyl)ethenyl)-, (e)- |
prontigenin |
rhapontin aglycone |
rhapontigenin is known as a natural analog of resveratrol. |
Rhapontigenin (RPG) is a stilben derivative and is known to bear several effects such as antiallergic, anticoagulative, hypoglycemic, antiangiogenic, and purgative. It is an active anti-cancer compound.
Excerpt | Reference | Relevance |
---|---|---|
"Rhapontigenin (RPG) is a stilben derivative and is known to bear several effects such as antiallergic, anticoagulative, hypoglycemic, antiangiogenic, and purgative. " | ( Cardioprotective Effect of Rhapontigenin in Isoproterenol-Induced Myocardial Infarction in a Rat Model. Fan, Y, 2019) | 2.25 |
"Rhapontigenin is an active anti-cancer compound." | ( Preparative enzymatic synthesis and HPLC analysis of rhapontigenin: applications to metabolism, pharmacokinetics and anti-cancer studies. Davies, NM; Halls, SC; Helms, GL; Roupe, KA; Yáñez, JA, 2005) | 1.3 |
Excerpt | Reference | Relevance |
---|---|---|
"Rhapontigenin (1) has various biological activities including anticancer activities." | ( Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. Kang, CG; Kim, JS; Kim, SH; Lee, EO, 2014) | 2.57 |
Excerpt | Reference | Relevance |
---|---|---|
" The developed HPLC assay is sensitive, reproducible and accurate and can be applied to pharmacokinetic and metabolism studies." | ( Preparative enzymatic synthesis and HPLC analysis of rhapontigenin: applications to metabolism, pharmacokinetics and anti-cancer studies. Davies, NM; Halls, SC; Helms, GL; Roupe, KA; Yáñez, JA, 2005) | 0.58 |
Excerpt | Reference | Relevance |
---|---|---|
" The estimates of oral bioavailability characterize these stilbenes as poorly bioavailable compounds." | ( Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats. Davies, NM; Roupe, KA; Teng, XW; Yáñez, JA, 2006) | 0.6 |
" However, there is no information describing the pharmacokinetics, bioavailability and metabolism of rhaponticin after intravenous administration." | ( Pharmacokinetics, bioavailability and metabolism of rhaponticin in rat plasma by UHPLC-Q-TOF/MS and UHPLC-DAD-MSn. Bai, X; Cheng, XL; Lin, RC; Su, Q; Tan, XJ; Zhao, YY, 2012) | 0.38 |
"UHPLC-Q-TOF/MS and UHPLC-multistage tandem MS methods were developed for the pharmacokinetics, bioavailability and metabolism of rhaponticin in rats." | ( Pharmacokinetics, bioavailability and metabolism of rhaponticin in rat plasma by UHPLC-Q-TOF/MS and UHPLC-DAD-MSn. Bai, X; Cheng, XL; Lin, RC; Su, Q; Tan, XJ; Zhao, YY, 2012) | 0.38 |
"The present pharmacokinetics, bioavailability and metabolism studies of rhaponticin will provide helpful information for development of suitable dosage forms and clinical references on rational administration." | ( Pharmacokinetics, bioavailability and metabolism of rhaponticin in rat plasma by UHPLC-Q-TOF/MS and UHPLC-DAD-MSn. Bai, X; Cheng, XL; Lin, RC; Su, Q; Tan, XJ; Zhao, YY, 2012) | 0.38 |
Excerpt | Relevance | Reference |
---|---|---|
"The present pharmacokinetics, bioavailability and metabolism studies of rhaponticin will provide helpful information for development of suitable dosage forms and clinical references on rational administration." | ( Pharmacokinetics, bioavailability and metabolism of rhaponticin in rat plasma by UHPLC-Q-TOF/MS and UHPLC-DAD-MSn. Bai, X; Cheng, XL; Lin, RC; Su, Q; Tan, XJ; Zhao, YY, 2012) | 0.38 |
Class | Description |
---|---|
stilbenoid | Any olefinic compound characterised by a 1,2-diphenylethylene backbone. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1157245 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells assessed as suppression of serum-induced cell migration at 10 uM after 24 hrs by wound-healing assay relative to control | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1157268 | Effect on total PI3K protein level in human MDA-MB-231 cells at 10 to 50 uM after 24 hrs by Western blot analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID82976 | In vitro concentration required to induce apoptosis in HL60 cells | 2003 | Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16 | Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. |
AID1354540 | Antiinflammatory activity in mouse J774 cells assessed as reduction in LPS-induced nitric oxide production after 24 hrs by Griess assay | 2018 | Journal of natural products, 05-25, Volume: 81, Issue:5 | Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner. |
AID1667363 | Inhibition of alpha-glucosidase (unknown origin) using p-NPG as substrate by Dixon plot analysis | 2020 | Bioorganic & medicinal chemistry letters, 04-15, Volume: 30, Issue:8 | Tetra-aryl cyclobutane and stilbenes from the rhizomes of Rheum undulatum and their α-glucosidase inhibitory activity: Biological evaluation, kinetic analysis, and molecular docking simulation. |
AID1374190 | Estrogenic activity at ERalpha/ERbeta (unknown origin) expressed in human HepG2 cells co-expressing ERE-dependent promoter assessed as increase in ER-mediated transcriptional activation at 10 uM incubated for 24 hrs by luciferase reporter gene assay relat | 2018 | Bioorganic & medicinal chemistry letters, 02-15, Volume: 28, Issue:4 | Estrogenic activity of constituents from the rhizomes of Rheum undulatum Linné. |
AID1372028 | Antioxidant activity assessed as relative scavenging rate constant for photolysis-induced peroxyl scavenging activity by measuring Kaox/Kst ratio using CYPMPO spin trap by ESR spectroscopic method | 2017 | Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23 | Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical. |
AID1157259 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells assessed as inhibition of PAK1 phosphorylation at 10 to 50 uM after 24 hrs by Western blot analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1372020 | Antioxidant activity assessed as Trolox equivalents of photolysis-induced methyl radical scavenging activity using DMPO spin trap by ESR spectroscopic method | 2017 | Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23 | Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical. |
AID1157266 | Inhibition of PI3K phosphorylation in human MDA-MB-231 cells at 10 to 50 uM after 24 hrs by Western blot analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1372027 | Antioxidant activity assessed as relative scavenging rate constant for photolysis-induced alkoxyl scavenging activity by measuring Kaox/Kst ratio using DMPO spin trap by ESR spectroscopic method | 2017 | Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23 | Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical. |
AID1372026 | Antioxidant activity assessed as relative scavenging rate constant for photolysis-induced methyl radical scavenging activity by measuring Kaox/Kst ratio using DMPO spin trap by ESR spectroscopic method | 2017 | Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23 | Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical. |
AID1667362 | Mixed inhibition of alpha-glucosidase (unknown origin) using p-NPG as substrate by Lineweaver-Burk plot analysis | 2020 | Bioorganic & medicinal chemistry letters, 04-15, Volume: 30, Issue:8 | Tetra-aryl cyclobutane and stilbenes from the rhizomes of Rheum undulatum and their α-glucosidase inhibitory activity: Biological evaluation, kinetic analysis, and molecular docking simulation. |
AID1372030 | Antioxidant activity assessed as relative scavenging rate constant for photolysis-induced singlet oxygen scavenging activity by measuring Kaox/Kst ratio using 4-HO-TEMP spin trap by ESR spectroscopic method | 2017 | Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23 | Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical. |
AID82982 | In vitro inhibitory concentration against proliferation of HL60 cells | 2003 | Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16 | Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. |
AID1157247 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells assessed as suppression of serum-induced cell migration at 50 uM after 24 hrs by wound-healing assay relative to control | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1372019 | Antioxidant activity assessed as Trolox equivalents of photolysis-induced hydroxyl radical scavenging activity using DMPO spin trap by ESR spectroscopic method | 2017 | Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23 | Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical. |
AID1354538 | Inhibition of PI3K/Akt in mouse J774 cells assessed as reduction in LPS-induced Akt phosphorylation at Ser473 after 4 hrs by Western blot analysis | 2018 | Journal of natural products, 05-25, Volume: 81, Issue:5 | Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner. |
AID1354542 | Antiinflammatory activity in mouse J774 cells assessed as reduction in LPS-induced MCP1 expression after 24 hrs by ELISA | 2018 | Journal of natural products, 05-25, Volume: 81, Issue:5 | Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner. |
AID1372024 | Antioxidant activity assessed as Trolox equivalents of photolysis-induced singlet oxygen scavenging activity using 4-HO-TEMP spin trap by ESR spectroscopic method | 2017 | Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23 | Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical. |
AID1157269 | Effect on total AKT protein level in human MDA-MB-231 cells at 10 to 50 uM after 24 hrs by Western blot analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1372022 | Antioxidant activity assessed as Trolox equivalents of photolysis-induced peroxyl scavenging activity using CYPMPO spin trap by ESR spectroscopic method | 2017 | Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23 | Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical. |
AID1157262 | Effect on total PAK1 protein level in human MDA-MB-231 cells at 10 to 50 uM after 24 hrs by Western blot analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID132501 | Inhibitory activity against nitric oxide production in LPS-activated mouse peritoneal macrophages | 2000 | Bioorganic & medicinal chemistry letters, Feb-21, Volume: 10, Issue:4 | Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages. |
AID1157250 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells assessed as suppression of serum-induced cell invasion into matrigel at 50 uM preincubated for 30 mins with cells followed by loading into upper well of matrigel coated filter measured | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1157244 | Cytotoxicity against human MDA-MB-231 cells assessed as cell viability up to 50 uM after 24 hrs by MTT assay | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1157255 | Inhibition of PI3K in human MDA-MB-231 cells assessed as downregulation of activated Rac1-GTP protein expression at 50 uM after 30 mins by Western blot analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID37425 | Inhibitory activity against yeast alpha-glucosidase; active | 2004 | Bioorganic & medicinal chemistry letters, Jul-16, Volume: 14, Issue:14 | Yeast and mammalian alpha-glucosidase inhibitory constituents from Himalayan rhubarb Rheum emodi Wall.ex Meisson. |
AID1157248 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells assessed as suppression of serum-induced cell invasion into matrigel at 10 uM preincubated for 30 mins with cells followed by loading into upper well of matrigel coated filter measured | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1157256 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells assessed as downregulation of WAVE-2 protein expression at 10 to 50 uM after 24 hrs by Western blot analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1157251 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells at 10 uM after 30 mins by ELISA relative to untreated control | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1157264 | Effect on total cofilin protein level in human MDA-MB-231 cells at 10 to 50 uM after 24 hrs by Western blot analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1157263 | Effect on total LIMK1/2 protein level in human MDA-MB-231 cells at 10 to 50 uM after 24 hrs by Western blot analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1157257 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells assessed as downregulation of Arp-2 protein expression at 10 to 50 uM after 24 hrs by Western blot analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1157261 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells assessed as inhibition of cofilin phosphorylation at 10 to 50 uM after 24 hrs by Western blot analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1374189 | Estrogenic activity at ERalpha/ERbeta (unknown origin) expressed in human HepG2 cells co-expressing ERE-dependent promoter assessed as increase in ER-mediated transcriptional activation at 1 uM incubated for 24 hrs by luciferase reporter gene assay relati | 2018 | Bioorganic & medicinal chemistry letters, 02-15, Volume: 28, Issue:4 | Estrogenic activity of constituents from the rhizomes of Rheum undulatum Linné. |
AID1372025 | Antioxidant activity assessed as relative scavenging rate constant for photolysis-induced hydroxyl radical scavenging activity by measuring Kaox/Kst ratio using DMPO spin trap by ESR spectroscopic method | 2017 | Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23 | Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical. |
AID1157246 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells assessed as suppression of serum-induced cell migration at 25 uM after 24 hrs by wound-healing assay relative to control | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1157258 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells assessed as downregulation of Arp-3 protein expression at 10 to 50 uM after 24 hrs by Western blot analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1157252 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells at 25 uM after 30 mins by ELISA relative to untreated control | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1372021 | Antioxidant activity assessed as Trolox equivalents of photolysis-induced alkoxyl scavenging activity using DMPO spin trap by ESR spectroscopic method | 2017 | Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23 | Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical. |
AID1157254 | Effect on total Rac1 protein expression in human MDA-MB-231 cells after 30 mins by Western blot analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1372023 | Antioxidant activity assessed as Trolox equivalents of photolysis-induced superoxide anion scavenging activity using CYPMPO spin trap by ESR spectroscopic method | 2017 | Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23 | Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical. |
AID1354541 | Antiinflammatory activity in mouse J774 cells assessed as reduction in LPS-induced IL6 expression after 24 hrs by ELISA | 2018 | Journal of natural products, 05-25, Volume: 81, Issue:5 | Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner. |
AID1372032 | Antioxidant activity assessed as rate constant for photolysis-induced methyl radical scavenging activity using DMPO spin trap by ESR spectroscopic method | 2017 | Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23 | Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical. |
AID1372029 | Antioxidant activity assessed as relative scavenging rate constant for photolysis-induced super-oxide anion scavenging activity by measuring Kaox/Kst ratio using CYPMPO spin trap by ESR spectroscopic method | 2017 | Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23 | Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical. |
AID1157249 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells assessed as suppression of serum-induced cell invasion into matrigel at 25 uM preincubated for 30 mins with cells followed by loading into upper well of matrigel coated filter measured | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1667360 | Inhibition of alpha-glucosidase (unknown origin) using p-NPG as substrate by spectrophotometric analysis | 2020 | Bioorganic & medicinal chemistry letters, 04-15, Volume: 30, Issue:8 | Tetra-aryl cyclobutane and stilbenes from the rhizomes of Rheum undulatum and their α-glucosidase inhibitory activity: Biological evaluation, kinetic analysis, and molecular docking simulation. |
AID1157265 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells assessed as inhibition of lamellipodia formation at 50 uM after 24 hrs by rhodamine phalloidin/DAPI staining-based confocal microscopic analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1157253 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells at 50 uM after 30 mins by ELISA relative to untreated control | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1157243 | Cytotoxicity against human MDA-MB-231 cells assessed as cell viability at 100 to 200 uM after 24 hrs by MTT assay | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1157260 | Inhibition of PI3K-dependent Rac1 activation in human MDA-MB-231 cells assessed as inhibition of LIMK1/2 phosphorylation at 10 to 50 uM after 24 hrs by Western blot analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
AID1157267 | Inhibition of PI3K in human MDA-MB-231 cells assessed as inhibition of AKT phosphorylation at 10 to 50 uM after 24 hrs by Western blot analysis | 2014 | Journal of natural products, May-23, Volume: 77, Issue:5 | Rhapontigenin suppresses cell migration and invasion by inhibiting the PI3K-dependent Rac1 signaling pathway in MDA-MB-231 human breast cancer cells. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (25.71) | 29.6817 |
2010's | 19 (54.29) | 24.3611 |
2020's | 7 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (26.61) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (5.71%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 33 (94.29%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |